No Data
US Manufacturing Index Rises To 43, Highest Since 2020
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Has Caught The Eye Of Investors
Amphastar Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Amphastar Pharma Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Financial Results.
Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $66
No Data
No Data
